KPWG
ABBV icon

KFA Private Wealth Group’s AbbVie ABBV Stock Holding History

KFA Private Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$461K Buy
1,761
+21
+1% +$5.38K 0.11% 87
2026
Q2 		$438K Sell
1,740
-167
-9% -$35.9K 0.11% 90
2026
Q1 		$415K Sell
1,907
-108
-5% -$24K 0.1% 96
2025
Q4 		$461K Buy
2,015
+231
+13% +$52.6K 0.11% 85
2025
Q3 		$413K Sell
1,784
-201
-10% -$40.9K 0.12% 80
2025
Q2 		$369K Sell
1,985
-110
-5% -$20.4K 0.11% 87
2025
Q1 		$439K Buy
2,095
+160
+8% +$31.1K 0.15% 67
2024
Q4 		$344K Buy
1,935
+217
+13% +$39.9K 0.14% 65
2024
Q3 		$339K Buy
1,718
+419
+32% +$78.2K 0.16% 59
2024
Q2 		$223K Sell
1,299
-1,060
-45% -$176K 0.12% 71
2024
Q1 		$430K Buy
2,359
+207
+10% +$35.7K 0.13% 69
2023
Q4 		$334K Buy
2,152
+8
+0.4% +$1.17K 0.12% 67
2023
Q3 		$320K Sell
2,144
-6
-0.3% -$881 0.13% 62
2023
Q2 		$290K Sell
2,150
-413
-16% -$60.6K 0.12% 65
2023
Q1 		$409K Buy
2,563
+694
+37% +$106K 0.19% 49
2022
Q4 		$302K Sell
1,869
-268
-13% -$41.1K 0.15% 51
2022
Q3 		$287K Sell
2,137
-13
-0.6% -$1.86K 0.15% 51
2022
Q2 		$329K Sell
2,150
-68
-3% -$10.4K 0.18% 48
2022
Q1 		$360K Buy
2,218
+7
+0.3% +$1.02K 0.18% 49
2021
Q4 		$299K Buy
2,211
+7
+0.3% +$827 0.15% 58
2021
Q3 		$238K Buy
2,204
+165
+8% +$18.9K 0.13% 66
2021
Q2 		$230K Buy
2,039
+121
+6% +$13.6K 0.13% 65
2021
Q1 		$208K Buy
1,918
+5
+0.3% +$535 0.12% 74
2020
Q4 		$205K Buy
+1,913
New +$184K 0.13% 69

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

KFA Private Wealth Group's ABBV Position: Q3 2026 in Review

KFA Private Wealth Group increased its AbbVie (ABBV) stake by 1.2% in Q3 2026, buying an estimated $5.38K and bringing the position to 1,761 shares worth $461K. The position accounts for 0.11% of the portfolio, ranked #87.

KFA Private Wealth Group first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • KFA Private Wealth Group held 1,761 shares of AbbVie worth $461K as of Q3 2026.
  • KFA Private Wealth Group bought 21 AbbVie shares in Q3 2026, an estimated $5.38K.
  • AbbVie made up 0.11% of KFA Private Wealth Group's portfolio in Q3 2026, its #87 holding.
  • KFA Private Wealth Group first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on KFA Private Wealth Group's 13F filing for Q3 2026, filed 7 Oct 2026.